Russell Investments Group
ABEO icon

Russell Investments Group’s Abeona Therapeutics ABEO Stock Holding History

Russell Investments Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63K Buy
14,054
+959
+7% +$4.79K ﹤0.01% 3239
2025
Q4 		$69K Buy
13,095
+6,013
+85% +$30.3K ﹤0.01% 3181
2025
Q3 		$37.4K Buy
+7,082
New +$44.9K ﹤0.01% 3389
2021
Q3 		– Sell
-37,279
Closed -$1.45M – 3023
2021
Q2 		$1.45M Buy
37,279
+28,621
+331% +$1.17M ﹤0.01% 2123
2021
Q1 		$406K Hold
8,658
– – ﹤0.01% 2607
2020
Q4 		$339K Buy
8,658
+3,519
+68% +$120K ﹤0.01% 2576
2020
Q3 		$131K Buy
+5,139
New +$324K ﹤0.01% 2919

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Russell Investments Group's ABEO Position: Q1 2026 in Review

Russell Investments Group increased its Abeona Therapeutics (ABEO) stake by 7.3% in Q1 2026, buying an estimated $4.79K and bringing the position to 14,054 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #3239.

Russell Investments Group first reported a position in ABEO in Q3 2020 and has held it in 7 quarters since. The position peaked at $1.45M in Q2 2021. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Russell Investments Group held 14,054 shares of Abeona Therapeutics worth $63K as of Q1 2026.
  • Russell Investments Group bought 959 Abeona Therapeutics shares in Q1 2026, an estimated $4.79K.
  • Abeona Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3239 holding.
  • Russell Investments Group first reported a position in Abeona Therapeutics in Q3 2020 and has held it in 7 quarters since.
  • Russell Investments Group's Abeona Therapeutics position peaked at $1.45M in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.